Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis

Journal of Clinical Investigation

Volumn 114, Issue 8, 2004, Pages 1117-1127

  Dohi, Takehiko ^a   Beltrami, Elena ^a   Wall, Nathan R ^a   Plescia, Janet ^a   Altieri, Dario C ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SURVIVIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CYTOSOL; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; MITOCHONDRION; MOLECULAR DYNAMICS; MULTIGENE FAMILY; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; APOPTOSIS; CASPASES; CELL HYPOXIA; CELL LINE, TUMOR; ENDOPEPTIDASE K; ENZYME ACTIVATION; ENZYME INHIBITORS; HELA CELLS; HUMANS; IN SITU NICK-END LABELING; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIA; NEOPLASM PROTEINS; NEOPLASMS; RECOMBINANT FUSION PROTEINS; STAUROSPORINE; SUBCELLULAR FRACTIONS;

EID: 9644278114     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200422222     Document Type: Article

References (40)

1. Hanahan, D., and Weinberg, R.A. 2000. The hallmarks of cancer. Cell. 100:57-70.
2. Evan, G.I., and Vousden, K.H. 2001. Proliferation, cell cycle and apoptosis in cancer. Nature. 411:342-348.
3. Cory, S., and Adams, J.M. 2002. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer. 2:647-656.
4. Zamzami, N., and Kroemer, G. 2001. The mitochondrion in apoptosis: how Pandora's box opens. Nat. Rev. Mol. Cell Biol. 2:67-71.
5. Martinou, J.C., and Green, D.R. 2001. Breaking the mitochondrial barrier. Nat. Rev. Mol. Cell Biol. 2:63-67.
6. Salvesen, G.S., and Duckett, C.S. 2002. IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3:401-410.
7. Hengartner, M.O. 2000. The biochemistry of apoptosis. Nature. 407:770-776.
8. Altieri, D.C. 2003. Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer. 3:46-54.
9. Li, F., et al. 1999. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat. Cell Biol. 1:461-466.
10. Giodini, A., et al. 2002. Regulation of microtubule stability and mitotic progression by survivin. Cancer Res. 62:2462-2467.
11. Wheatley, S.P., Carvalho, A., Vagnarelli, P., and Earnshaw, W.C. 2001. INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis. Curr. Biol. 11:886-890.
12. Lens, S.M., and Medema, R.H. 2003. The survivin/ aurora B complex: its role in coordinating tension and attachment. Cell Cycle. 2:507-510.
13. Velculescu, V.E., et al. 1999. Analysis of human transcriptomes. Nat. Genet. 23:387-388.
14. van't Veer, L.J., et al. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415:530-536.
15. van de Wetering, M., et al. 2002. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 111:241-250.
16. Fortugno, P., et al. 2002. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J. Cell Sci. 115:575-585.
17. Gottlieb, R.A., and Granville, D.J. 2002. Analyzing mitochondrial changes during apoptosis. Methods. 26:341-347.
18. Wang, X. 2001. The expanding role of mitochondria in apoptosis. Genes Dev. 15:2922-2933.
19. Dong, Z., et al. 2001. Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms. J. Biol. Chem. 276:18702-18709.
20. Beltrami, E., Plescia, J., Wilkinson, J.C., Duckett, C.S., and Altieri, D.C. 2004. Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis. J. Biol. Chem. 279:2077-2084.
21. Song, Z., Yao, X., and Wu, M. 2003. Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis. J. Biol. Chem. 278:23130-23140.
22. Ambrosini, G., Adida, C., and Altieri, D.C. 1997. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3:917-921.
23. cdc2 phosphorylation of survivin. Proc. Natl. Acad. Sci. U. S. A. 97:13103-13107.
24. Blanc-Brude, O.P., et al. 2003. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin. Cancer Res. 9:2683-2692.
25. Marusawa, H., et al. 2003. HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J. 22:2729-2740.
26. Scaffidi, C., et al. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1675-1687.
27. Kroemer, G., and Reed, J.C. 2000. Mitochondrial control of cell death. Nat. Med. 6:513-519.
28. Ekedahl, J., et al. 2002. Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells. Exp. Cell Res. 279:277-290.
29. Young, J.C., Moarefi, I., and Hartl, F.U. 2001. Hsp90: a specialized but essential protein-folding tool. J. Cell Biol. 154:267-273.
30. Young, J.C., Hoogenraad, N.J., and Hartl, F.U. 2003. Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70. Cell. 112:41-50.
31. Fortugno, P., et al. 2003. Regulation of survivin function by Hsp90. Proc. Natl. Acad. Sci. U. S. A. 100:13791-13796.
32. Kamal, A., et al. 2003. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature. 425:407-410.
33. Chen, J.G., Yang, C.P., Cammer, M., and Horwitz, S.B. 2003. Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res. 63:7891-7899.
34. Krajewski, S., et al. 1999. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 96:5752-5757.
35. Susin, S.A., et al. 1999. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J. Exp. Med. 189:381-394.
36. Dohi, T., et al. 2004. A IAP-IAP complex inhibits apoptosis. J. Biol. Chem. 279:34087-34090. doi:10.1074/jbc.C400236200.
37. Lens, S.M., et al. 2003. Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension. EMBO J. 22:2934-2947.
38. Debatin, K.M., Poncet, D., and Kroemer, G. 2002. Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene. 21:8786-8803.
39. Johnstone, R.W., Ruefli, A.A., and Lowe, S.W. 2002. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 108:153-164.
40. Mesri, M., Wall, N.R., Li, J., Kim, R.W., and Altieri, D.C. 2001. Cancer gene therapy using a survivin mutant adenovirus. J. Clin. Invest. 108:981-990. doi:10.1172/JC1200112983.